This inventor holds 1 USPTO granted patent. Top assignee: Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie “Gosudarstvenny Nauchny Tsentr Nauchno-Issledovatelsky Institut Organicheskikh Poluproduktov I Krasitelei” (Fgup “Gntts Niopik”). Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Gennady Lvovich Khromov: Innovator in Photodynamic Therapy
Introduction
Gennady Lvovich Khromov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of medicine, particularly in photodynamic therapy. His innovative approach aims to enhance treatment efficacy in oncology and dermatology.
Latest Patents
Khromov holds a patent for a method for photodynamic therapy and an applicator designed for its implementation. This invention focuses on sensitizing pathological surface formations using an applicator containing 5-aminolevulinic acid. The method involves irradiating the sensitized area with therapeutic optical radiation in the spectral range of 625-700 nm. The applicator is transparent in this range, allowing for effective treatment while monitoring the intensity of fluorescence in the tissues.
Career Highlights
Khromov is associated with the Federal State Unitary Enterprise "State Scientific Center for Research of Organic Intermediate Products and Dyes" (Fgup "Gntts Niopik"). His work has been pivotal in advancing photodynamic therapy techniques, which aim to improve patient outcomes while minimizing the use of sensitizing agents.
Collaborations
Throughout his career, Khromov has collaborated with notable colleagues, including Georgy Nikolaevich Vorozhtsov and Anatoly Borisovich Davydov. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
Gennady Lvovich Khromov's contributions to photodynamic therapy represent a significant advancement in medical technology. His innovative methods and collaborative efforts continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile